Skip to Main Content

Dr. Michael D. Geschwind is a neurologist at the UCSF Memory and Aging Center who specializes in assessing and treating rapidly progressive dementias, including prion diseases such as Creutzfeldt-Jakob disease. He helped establish a hospital program for the assessment of rapidly progressive dementias at UCSF Medical Center, the first of its kind in the country. He also helped establish a clinic for patients with autoimmune encephalopathies, or brain diseases resulting from attack by the patient's own immune system.

In his research, Geschwind studies cognitive dysfunction in movement disorders, such as Huntington's disease, corticobasal degeneration, progressive supranuclear palsy and other parkinsonian dementias.

Geschwind earned his medical degree and doctoral degree in neuroscience through the Medical Scientist Training Program, sponsored by the National Institutes of Health, at the Albert Einstein College of Medicine in New York. He completed an internship in internal medicine at Ronald Reagan UCLA Medical Center, a neurology residency at Johns Hopkins School of Medicine and a fellowship in behavioral neurology at the UCSF Memory and Aging Center. At UCSF School of Medicine, he is the Michael J. Homer Chair in Neurology.

  • Education

    Albert Einstein College of Medicine, 1996

  • Residencies

    John Hopkins Hospital, Neurology, 2000

  • Fellowships

    UCSF Medical Center, Neurobehavior, 2002

  • Board Certifications

    Neurology, American Board of Psychiatry and Neurology.

  • Academic Title


  • Languages


Where I see patients (2)

    Decorative Caduceus

    Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

    The motor section of the UHDRS assesses motor features of HD with standardized ratings of oculomotor function, dysarthria, chorea, dystonia, gait, and postural stability. UHDRS 99 Motor, UHDRS Diagnostic Confidence Level.


    Decorative Caduceus

    Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's...

    Safety will be assessed by adverse events (AEs) related to clinical safety laboratory tests, vital signs, electrocardiograms (ECGs), neurological and physical examinations, rAAV5 vector shedding, immunogenicity response, suicidali...


    Decorative Caduceus

    Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CAD...

    A composite Cognitive Executive Function Score will be reported based on data from two electronic assessments (Favorites and Match). Favorites tests both episodic and associative memory and consists of 2 learning trials followed b...


    Decorative Caduceus

    Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias